The Cochrane UGPD Group aims to use evidence from randomised controlled trials to answer practical questions on the prevention, treatment and rehabilitation of benign and malignant upper gastrointestinal and pancreatic diseases. This includes disorders of the oesophagus, stomach, duodenum and pancreas.
There are possible areas of mutual interest with other Cochrane Gastrointestinal Groups.
The UGPD group is broadly responsable for reviews pertaining to the following parts of the body.
- Pancreas (excluding Diabetes Mellitus related disorders)